SCHEMBL2801840

SCHEMBL2801840

Fc1cccc(Br)c1OCC1=CCN(Cc2ccccc2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
KDM1A O60341 1/20 0.36
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
DRD2 P14416 5/20 0.36
HTR1A P08908 3/20 0.36
HTR2A P28223 2/20 0.36
HTT P42858 1/20 0.36
DRD4 P21917 3/20 0.35
DRD3 P35462 3/20 0.35
SLC6A4 P31645 3/20 0.35
SLC6A2 P23975 2/20 0.35
SLC6A3 Q01959 2/20 0.35
SIGMAR1 Q99720 1/20 0.35
KDM4E B2RXH2 1/20 0.34
GAA P10253 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CCNT1 O60563 1/20 0.34
CDK9 P50750 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2800502 0.84 MEN1 (0.39) MEN1KMT2AKDM1ADRD2HTR1A
SCHEMBL14529899 0.84 TSHR (0.37) MEN1KMT2ADRD2HTR1AHTR2A
SCHEMBL326153 0.83 S1PR5 (0.36) MEN1KMT2AKDM1ADRD2HTR1A
SCHEMBL1588617 0.82 ALDH1A1 (0.42) DRD2HTR1AHTR2AHTTDRD4
SCHEMBL31543821 0.79 DDB1 (0.41) MEN1KMT2AMAOAMAOBDRD2
SCHEMBL2801046 0.79 CCNT1 (0.44) MEN1KMT2ASLC6A4KDM4EL3MBTL1
SCHEMBL2801222 0.79 CCNT1 (0.42) MEN1KMT2AHTTL3MBTL1CCNT1
SCHEMBL750748 0.78 DRD4 (0.38) MEN1KMT2ADRD2HTR1AHTR2A
SCHEMBL15004236 0.78 NPC1 (0.49) MEN1KMT2ADRD2HTR1AHTR2A
SCHEMBL25342431 0.77 IKZF1 (0.36) MEN1KMT2AMAOAMAOBDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2206714-B1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO LTD (JP) 2015-01-21 EP disclosed
US-8729264-B2 Agent for prevention and/or treatment of skin diseases KYOWA HAKKO KIRIN CO., LTD. (JP) 2014-05-20 US disclosed
CN-101878217-A Agent for prevention and/or treatment of skin diseases KYOWA HAKKO KIRIN CO LTD 2010-11-03 CN disclosed
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-10-07 US disclosed
EP-2206714-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES Kyowa Hakko Kirin Co., Ltd. (JP) 2010-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES TYR, CUTA, SERPINB1 MEN1 3065/4885KMT2A 2175/4885KDM1A 1362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.